GGrantIndex
← Leaderboards

Susan Marie Graham

University Of Washington

$6,599,661
Attributed
$10,559,827
Total exposure
10
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$13,188,579 · 11

By mechanism

R01$7,161,829 · 3
P30$3,188,833 · 2
R34$1,264,749 · 2
R21$915,488 · 2
K23$632,680 · 1
R13$25,000 · 1

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Resources

Research focus

ResourcesWashingtonUniversitiesKenyaAntiretroviral TherapyAfrica South Of The SaharaResearch PersonnelHiv InfectionsClinicCaringPublic HealthAids PreventionInnovationProviderDiagnosisScale UpBaseAcquired Immunodeficiency SyndromeViral Load ResultParticipantPersonsCountryDesignEpidemic

Grant awards (33)

WHO-recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya$646,815
R01 · FY2025 · AI · contact PI
WHO-recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya$290,440
R01 · FY2025 · AI · contact PI
WHO-recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya$257,502
R01 · FY2025 · AI · contact PI
University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)$1,407,886
P30 · FY2024 · MH · contact PI
WHO-recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya$1,245,739
R01 · FY2024 · AI · contact PI
University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)$971,811
P30 · FY2023 · MH · contact PI
Administrative Core$560,081
P30 · FY2023 · MH · contact PI
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa$367,416
R01 · FY2023 · MH · contact PI
University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)$249,055
P30 · FY2023 · MH · contact PI
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa$521,931
R01 · FY2022 · MH · contact PI
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa$548,545
R01 · FY2021 · MH · contact PI
Shikamana PrEP: A Community Participatory Approach to Integrating PrEP, Sexual Health, and Mental Health Services for GBMSM in Kenya$202,185
R34 · FY2021 · MH · contact PI
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa$441,832
R01 · FY2020 · MH · contact PI
Shikamana PrEP: A Community Participatory Approach to Integrating PrEP, Sexual Health, and Mental Health Services for GBMSM in Kenya$231,627
R34 · FY2020 · MH · contact PI
Social Frailty among Older Kenyan Women Living with and without HIV Infection$194,375
R21 · FY2020 · AG · contact PI
Principles of STI/HIV Research Course$25,000
R13 · FY2020 · AI · contact PI
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission$561,795
R01 · FY2019 · AI · contact PI
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa$525,780
R01 · FY2019 · MH · contact PI
Social Frailty among Older Kenyan Women Living with and without HIV Infection$233,250
R21 · FY2019 · AG · contact PI
Shikamana PrEP: A Community Participatory Approach to Integrating PrEP, Sexual Health, and Mental Health Services for GBMSM in Kenya$204,244
R34 · FY2019 · MH · contact PI
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission$576,362
R01 · FY2018 · AI · contact PI
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission$572,643
R01 · FY2017 · AI · contact PI
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission$605,029
R01 · FY2016 · AI · contact PI
Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease$215,207
R21 · FY2016 · HL · contact PI
Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease$272,656
R21 · FY2015 · HL · contact PI
Provider and Peer Support Intervention to Improve ART Adherence among Kenyan Men$199,273
R34 · FY2015 · MH · contact PI
Provider and Peer Support Intervention to Improve ART Adherence among Kenyan Men$199,273
R34 · FY2014 · MH · contact PI
Provider and Peer Support Intervention to Improve ART Adherence among Kenyan Men$228,147
R34 · FY2013 · MH · contact PI
Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy$126,671
K23 · FY2010 · AI · contact PI
Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy$126,440
K23 · FY2009 · AI · contact PI
Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy$126,216
K23 · FY2008 · AI · contact PI
Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy$126,791
K23 · FY2007 · AI · contact PI
Genital HIV-1 Shedding among Women Starting Second-Line Antiretroviral Therapy$126,562
K23 · FY2006 · AI · contact PI